Physician profile
Carolynn Young
NPI 1285615195
$11,178.77
in general payments reported to CMS, 2019-2025
37 companies · $426 in 2025
The $426 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,293 · 2020: $858 · 2021: $3,049 · 2022: $2,211 · 2023: $1,042 · 2024: $2,299 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,101 · Consulting Fee: $1,502 · Travel and Lodging: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,100.61 |
| Consulting Fee | $1,501.66 |
| Travel and Lodging | $165.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,205.95 | 2019-2023 | Da Vinci Sp |
| Gynesonics, INC. | $2,486.87 | 2021-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Abbvie INC. | $934.08 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Therapeuticsmd, INC. | $567.47 | 2019-2022 | |
| Renovia INC | $368.15 | 2019-2021 | |
| Caldera Medical, INC | $340.71 | 2021-2024 | Desara |
| Pfizer INC. | $329.69 | 2019-2024 | |
| Millicent US INC | $302.87 | 2019-2025 | Femring, Intrarosa, Femlyv |
| Exeltis, USA INC. | $258.21 | 2019-2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $213.05 | 2019-2025 | |
| Hologic Sales and Service, LLC | $200.58 | 2019-2025 | Aptima |
| Astellas Pharma US INC | $191.55 | 2019-2025 | Veozah |
| Axonics, INC. | $177.08 | 2022-2024 | Bulkamid |
| Myriad Women'S Health, INC. | $173.17 | 2023 | Myrisk |
| Allergan, INC. | $160.74 | 2019-2020 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $156.32 | 2019-2025 | On-Q Pump and Accessories |
| Coopersurgical, INC. | $128.13 | 2020-2024 | Advincula Delineator Uterine Manipulator, Mara Console, Paragard T 380a |
| Avion Pharmaceuticals | $98.38 | 2019-2022 | |
| Myovant Sciences INC. | $93.98 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $91.55 | 2021-2025 | |
| Vertical Pharmaceuticals, LLC | $87.84 | 2019-2020 | |
| Baxter Healthcare | $84.65 | 2021 | |
| Aspira Women'S Health INC | $82.32 | 2019-2024 | Ova1 |
| Merck Sharp & Dohme LLC | $65.61 | 2021-2025 | Gardasil 9, Gardasil |
| Amag Pharmaceuticals, INC. | $59.80 | 2019-2020 | |
| Lilly USA, LLC | $53.17 | 2025 | Zepbound |
| Evofem Biosciences, INC. | $37.55 | 2021-2022 | |
| Becton, Dickinson and Company | $35.37 | 2021-2024 | Bd Max System, Bd Max Instrument |
| Ethicon US, LLC | $32.40 | 2019-2024 | Dermabond, Vistaseal, Surgiflo Hemostatic Matrix |
| Agile Therapeutics, INC. | $28.74 | 2022-2023 | Twirla |
| Lupin INC. | $26.80 | 2020 | |
| Amgen INC. | $24.58 | 2020 | |
| Olympus America INC. | $22.32 | 2019 | |
| Inari Medical, INC. | $21.34 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Daiichi Sankyo INC. | $15.45 | 2021 | |
| Acessa Health INC. | $12.73 | 2020 | |
| Meditrina | $9.57 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carolynn Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.